Tailored mindfulness-based group intervention for psychological distress and adjustment for allogeneic hematopoietic stem cell transplant outpatients Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years of age and over 2. A diagnosis of haematologic cancer 3. Had undergone Hematopoietic stem cell transplant (HSCT) at least 30 days before enrolment in the study
Exclusion criteria
Exclusion criteria: 1. If they had comorbid medical issues 2. Significant cognitive impairment that interfered with their ability to attend the program 3. Were participating in other psychological treatments during the trial 4. Had a history of severe mental illness (e.g., schizophrenia or bipolar disorder) 5. Did not read, write, or understand English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured at T1: baseline; T2: 6 weeks post intervention; T3: 3 months post intervention: 1. Level of depression measured using the Beck Depression Inventory (BDI-II) 2. Level of anxiety measured using the State-Trait Anxiety Inventory (STAI) 3. Quality of life measured using the Functional Assessment of Cancer Therapy – Bone Marrow Transplant (FACT-BMT) 4. Level of psychological adjustment measured using the Mini-Mental Adjustment to Cancer Scale (Mini-MAC) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at T1: baseline; T2: 6 weeks post intervention; T3: 3 months post intervention: 1. Mindfulness skills were assessed using the Five Facet Mindfulness Questionnaire (FFMQ) 2. Emotion regulation skills were measured with the Emotion Regulation Questionnaire (ERQ) 3. Decentring was measured with the Experiences Questionnaire (EQ) 4. Health domains affected by cancer measured using the Patient-Reported Outcome Measurement Information System (PROMIS) Cancer Scales, including fatigue, pain interference, physical functioning, and emotional distress 5. The tailored group mindfulness program's acceptability and feasibility measured using data collected during a treatment evaluation questionnaire and an optional 30-minute qualitative interview | — |
Countries
Australia